Showing results (41-50 of 125) with videos related to
Sort By:
Pageof 13
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|January 10, 2020
The effects of aerobic training on subclinical negative affect: A randomized controlled trialKathleen M McIntyre, Eli Puterman, Jennifer M Scodes, et al.Women & Health|April 3, 2020
Exploring gender differences among treatment-seekers who use opioids versus alcohol and other drugsTanya C Saraiya, Martina Pavlicova, Mei-Chen Hu, et al.AIDS Care|November 5, 2019
DSM-5 substance use disorder symptom clusters and HIV antiretroviral therapy (ART) adherenceMargaret M Paschen-Wolff, Aimee N C Campbell, Susan Tross, et al.Addiction Biology|December 8, 2021
Baseline- and treatment-associated pain in the X:BOT comparative effectiveness study of extended-release naltrexone versus buprenorphine-naloxone for OUDAn-Li Wang, Matisyahu Shulman, Tse-Hwei Choo, et al.The American Journal of Drug and Alcohol Abuse|July 11, 2025
Suicidal ideation in adults with opioid use disorder treated with buprenorphine-naloxone versus extended-release naltrexoneMina M Rizk, Barbara Stanley, Tse-Hwei Choo, et al.The American Journal on Addictions|February 20, 2018
Abstinence and reduced frequency of use are associated with improvements in quality of life among treatment-seekers with cannabis use disorderChristina A Brezing, C Jean Choi, Martina Pavlicova, et al.Journal of Urban Health : Bulletin of the New York Academy of Medicine|November 19, 2009
Relationship power and sexual risk among women in community-based substance abuse treatmentAimee N C Campbell, Susan Tross, Shari L Dworkin, et al.The American Journal of Drug and Alcohol Abuse|April 2, 2021
Open-label pilot study of lisdexamfetamine for cocaine use disorderJohn J Mariani, C Jean Choi, Martina Pavlicova, et al.Journal of Attention Disorders|April 2, 2016
ADHD Is Highly Prevalent in Patients Seeking Treatment for Cannabis Use DisordersDaniel P Notzon, Martina Pavlicova, Andrew Glass, et al.The American Journal of Psychiatry|June 25, 2021
Sublingual Buprenorphine-Naloxone Compared With Injection Naltrexone for Opioid Use Disorder: Potential Utility of Patient Characteristics in Guiding Choice of TreatmentEdward V Nunes, Jennifer M Scodes, Martina Pavlicova, et al.Pageof 13